House Progressives Push to Expand Scope of Drug-Pricing Measure

Progressives in the House are pushing for further changes to legislation that would direct the government to negotiate with drugmakers on the price of medicines and are considering offering floor amendments if needed, lawmakers said.

Leaders of the Congressional Progressive Caucus, which represents the most liberal House Democrats, have been pushing to expand the number and range of medicines subject to government negotiation under the drug-pricing bill (H.R. 3). They made some progress amid a trio of congressional committee hearings, but are still negotiating with Democratic leaders for more.

Progressive leaders say they want the most expansive drug-pricing ...